IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer
Clinical trial NCT05124795 · TERMINATED
Trial details
- NCT number
- NCT05124795
- Sponsor
- Immunic AG
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-09
- Primary completion
- 2023-05-31
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.